Literature DB >> 4100018

Increased susceptibility of red-blood-cell lipids to autooxidation in haemolytic states.

J Stocks, M Kemp, T L Dormandy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4100018     DOI: 10.1016/s0140-6736(71)91004-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Haemolytic syndrome associated with a red cell lipid abnormality.

Authors:  A J Barnes; J M Gutteridge; J Stocks; T L Dormandy
Journal:  Br Med J       Date:  1973-05-26

2.  Vitamin E in neonatal hyperbilirubinaemia.

Authors:  B A Abrams; J M Gutteridge; J Stocks; M Friedman; T L Dormandy
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

3.  Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone.

Authors:  B D Goldstein; E M McDonagh
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

4.  Human erythrocyte superoxide dismutase activity during deep diving.

Authors:  J A Paciorek
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

5.  Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria.

Authors:  I A Clark; N H Hunt
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Antioxidant enzyme alterations in experimental and clinical diabetes.

Authors:  D V Godin; S A Wohaieb; M E Garnett; A D Goumeniouk
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

7.  The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.

Authors:  S Túri; I Németh; I Varga; T Bodrogi; B Matkovics
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

8.  Administration of antioxidants in chronic kidney disease.

Authors:  Mohamad Reza Tamadon; Mehrdad Zahmatkesh; Seyed Seifollah Beladi Mousavi
Journal:  J Nephropharmacol       Date:  2015-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.